REFERENCES
- Scott IU, Edwards AR, Beck RW, et al. A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology. 2007; 114(10): 1860–1867.
- Scott IU, Ip MS, VanVeldhuisen PC, et al. SCORE Study Report 6: a randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. Arch Ophthalmol. 2009; 127(9): 1115–1128.
- Ip MS, Scott IU, VanVeldhuisen PC, et al. SCORE Study Report 5: a randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Arch Ophthalmol. 2009; 127(9): 1101–1114.
- Fung AE, Lalwani GA, Rosenfeld PJ, et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol. 2007; 143(4): 566–583.
- Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology. 1991; 98(5 Suppl): 786–806.
- Davis MD, Bressler SB, Aiello LP, et al. Comparison of time-domain OCT and fundus photographic assessments of retinal thickening in eyes with diabetic macular edema. Invest Ophthalmol Vis Sci. 2008; 49(5): 1745–1752.
- Wilkins JR, Puliafito CA, Hee MR, et al. Characterization of epiretinal membranes using optical coherence tomography. Ophthalmology. 1996; 103(12): 2142–2151.
- Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group. The Multicenter Uveitis Steroid Treatment Trial: rationale, design, and baseline characteristics. Am J Ophthalmol. 2010; 149(4): 550–561. e10.
- Domalpally A, Blodi BA, Scott IU, et al. SCORE Study Report 4: The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study system for evaluation of optical coherence tomograms: SCORE study report 4. Arch Ophthalmol. 2009; 127(11): 1461–1467.
- Domalpally A, Danis RP, Zhang B, Myers D, Kruse CN. Quality issues in interpretation of optical coherence tomograms in macular diseases. Retina. 2009; 29(6): 775–781.
- Hee MR. Artifacts in optical coherence tomography topographic maps. Am J Ophthalmol. 2005; 139(1): 154–155.
- Ray R, Stinnett SS, Jaffe GJ. Evaluation of image artifact produced by optical coherence tomography of retinal pathology. Am J Ophthalmol. 2005; 139(1): 18–29.
- Gupta V, Gupta P, Singh R, Dogra MR, Gupta A. Spectral-domain Cirrus high-definition optical coherence tomography is better than time-domain Stratus optical coherence tomography for evaluation of macular pathologic features in uveitis. Am J Ophthalmol. 2008; 145(6): 1018–1022.
- Markomichelakis NN, Halkiadakis I, Pantelia E, et al. Patterns of macular edema in patients with uveitis: qualitative and quantitative assessment using optical coherence tomography. Ophthalmology. 2004; 111(5): 946–953.
- Glassman AR, Beck RW, Browning DJ, Danis RP, Kollman C. Comparison of optical coherence tomography in diabetic macular edema, with and without reading center manual grading from a clinical trials perspective. Invest Ophthalmol Vis Sci. 2009; 50(2): 560–566. Epub 2008 Jun 19.
- Han IC, Jaffe GJ. Evaluation of artifacts associated with macular spectral-domain optical coherence tomography. Ophthalmology. 2010; 117(6): 1177–1189.
- Domalpally A, Gangaputra S, Peng Q, Danis RP. Repeatability of retinal thickness measurements between spectral-domain and time-domain optical coherence tomography images in macular disease. Ophthalmic Surg Lasers Imaging. 2010; 41(6): S34–S41.
- Chang LK, Fine HF, Spaide RF, Koizumi H, Grossniklaus HE. Ultrastructural correlation of spectral-domain optical coherence tomographic findings in vitreomacular traction syndrome. Am J Ophthalmol. 2008; 146(1): 121–127.